SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases

BACKGROUND: Stereotactic radiosurgery (SRS) is a frequently chosen treatment for patients with brain metastases and the number of long-term survivors is increasing. Brain necrosis (e.g. radionecrosis) is the most important long-term side effect of the treatment. Retrospective studies show a lower ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Crouzen, J. A., Petoukhova, A. L., Broekman, M. L. D., Fiocco, M., Fisscher, U. J., Franssen, J. H., Gadellaa-van Hooijdonk, C. G. M., Kerkhof, M., Kiderlen, M., Mast, M. E., van Rij, C. M., Nandoe Tewarie, R., van de Sande, M. A. E., van der Toorn, P. P. G., Vlasman, R., Vos, M. J., van der Voort van Zyp, N. C. M. G., Wiggenraad, R. G. J., Wiltink, L. M., Zindler, J. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039548/
https://www.ncbi.nlm.nih.gov/pubmed/36964529
http://dx.doi.org/10.1186/s12885-023-10761-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039548/
https://www.ncbi.nlm.nih.gov/pubmed/36964529
http://dx.doi.org/10.1186/s12885-023-10761-1

Ejemplares similares